![logo](/logos/NWBO.webp)
Northwest Biotherapeutics, Inc.
OTC:NWBO
0.7 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Northwest Biotherapeutics, Inc. |
Symbool | NWBO |
Munteenheid | USD |
Prijs | 0.823 |
Beurswaarde | 957,167,047 |
Dividendpercentage | 0% |
52-weken bereik | 0.4 - 1.27 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Linda F. Powers J.D. |
Website | https://www.nwbio.com |
An error occurred while fetching data.
Over Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)